Targeting CDH17 with Chimeric Antigen Receptor-Redirected T Cells in Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting CDH17 with Chimeric Antigen Receptor-Redirected T Cells in Small Cell Lung Cancer

Published:2023-10 Issue:5 Volume:201 Page:489-497
ISSN:0341-2040
Container-title:Lung
language:en
Short-container-title:Lung

Author:

Tian Wen,Zhao Jinhui,Wang Wenzhong

Funder

Cangzhou Science and Technology Plan Project

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00408-023-00648-0.pdf

Reference23 articles.

1. Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A (2021) Epidemiology of lung cancer. Contemp Oncol (Pozn) 25:45–52. https://doi.org/10.5114/wo.2021.103829

2. Jackman DM, Johnson BE (2005) Small-cell lung cancer. Lancet 366:1385–1396. https://doi.org/10.1016/S0140-6736(05)67569-1

3. Rades D, Dziggel L, Segedin B, Oblak I, Nagy V, Marita A, Schild SE (2013) The first survival score for patients with brain metastases from small cell lung cancer (SCLC). Clin Neurol Neurosurg 115:2029–2032. https://doi.org/10.1016/j.clineuro.2013.06.019

4. Wang M, Herbst RS, Boshoff C (2021) Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med 27:1345–1356. https://doi.org/10.1038/s41591-021-01450-2

5. Yang WC, Hsu FM, Yang PC (2020) Precision radiotherapy for non-small cell lung cancer. J Biomed Sci 27:82. https://doi.org/10.1186/s12929-020-00676-5

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity;Advanced Science;2024-06-18

2. LUNG Year in Review: 2023;Lung;2024-02

3. Better safe than sorry: dual targeting antibodies for cancer immunotherapy;Biological Chemistry;2024-02-01

4. Cadherin 17 Nanobody-Mediated Near-Infrared-II Fluorescence Imaging-Guided Surgery and Immunotoxin Delivery for Colorectal Cancer;Biomaterials Research;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3